Cargando…

Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours

BACKGROUND: TARDOX is a Phase I single center study of ultrasound triggered targeted drug delivery in adult oncology patients with incurable liver tumours. This proof of concept study is designed to demonstrate the safety and feasibility of targeted drug release and enhanced delivery of doxorubicin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyon, Paul C., Griffiths, Lucy F., Lee, Jenni, Chung, Daniel, Carlisle, Robert, Wu, Feng, Middleton, Mark R., Gleeson, Fergus V., Coussios, Constantin C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667032/ https://www.ncbi.nlm.nih.gov/pubmed/29118984 http://dx.doi.org/10.1186/s40349-017-0104-0

Ejemplares similares

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound
por: Spiers, Laura, et al.
Publicado: (2023)

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial
por: Lyon, Paul C, et al.
Publicado: (2018)

Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model
por: Swenson, Christine E., et al.
Publicado: (2015)

Thermosensitive Polymers and Thermo-Responsive Liposomal Drug Delivery Systems
por: Abuwatfa, Waad H., et al.
Publicado: (2022)

Quantifying cell death induced by doxorubicin, hyperthermia or HIFU ablation with flow cytometry
por: Lyon, Paul Christopher, et al.
Publicado: (2021)

Targeting of Liposomes via PSGL1 for Enhanced Tumor Accumulation
por: Carlisle, Robert, et al.
Publicado: (2012)

A Mathematical Model for Thermosensitive Liposomal Delivery of Doxorubicin to Solid Tumour
por: Zhan, Wenbo, et al.
Publicado: (2013)

Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.
por: Goebel, F. D., et al.
Publicado: (1996)

Therapeutic Efficacy of Combining PEGylated Liposomal Doxorubicin and Radiofrequency (RF) Ablation: Comparison between Slow-Drug-Releasing, Non-Thermosensitive and Fast-Drug-Releasing, Thermosensitive Nano-Liposomes
por: Andriyanov, Alexander V., et al.
Publicado: (2014)

Doxorubicin Loaded Thermosensitive Magneto-Liposomes Obtained by a Gel Hydration Technique: Characterization and In Vitro Magneto-Chemotherapeutic Effect Assessment
por: Nitica, Stefan, et al.
Publicado: (2022)

Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild Hyperthermia
por: Dicheva, Bilyana M., et al.
Publicado: (2015)

Assessment of Intratumoral Doxorubicin Penetration after Mild Hyperthermia-Mediated Release from Thermosensitive Liposomes
por: Derieppe, Marc, et al.
Publicado: (2019)

Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
por: Lyon, Paul C., et al.
Publicado: (2018)

Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in de novo stage IV breast cancer patients: study protocol of the i-GO study
por: de Maar, Josanne S, et al.
Publicado: (2020)

Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities
por: Motamarry, Anjan, et al.
Publicado: (2022)

Preparation and Evaluation of Thermosensitive Liposomes Encapsulating I-125-Labeled Doxorubicin Derivatives for Auger Electron Therapy
por: Elghobary, Mohamed Elsaid Nasr, et al.
Publicado: (2023)

Review of the Delivery Kinetics of Thermosensitive Liposomes
por: Haemmerich, Dieter, et al.
Publicado: (2023)

Co-Delivery of Doxorubicin and SATB1 shRNA by Thermosensitive Magnetic Cationic Liposomes for Gastric Cancer Therapy
por: Peng, Zhao, et al.
Publicado: (2014)

Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy
por: Rezaeian, Mohsen, et al.
Publicado: (2019)

CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model
por: Liu, Qiqian, et al.
Publicado: (2020)

Enzyme and Thermo Dual-stimuli Responsive DOX Carrier Based on PNIPAM Conjugated Mesoporous Silica
por: Ebrahimi, Seyyed Mostafa, et al.
Publicado: (2022)

Current developments in drug delivery with thermosensitive liposomes
por: Bi, Hongshu, et al.
Publicado: (2019)

Correction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model
por: Liu, Qiqian, et al.
Publicado: (2022)

The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo
por: Wang, Chao, et al.
Publicado: (2015)

Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin
por: Weng, Chia-Sui, et al.
Publicado: (2019)

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model
por: Igarashi, Kentaro, et al.
Publicado: (2018)

Cavitation-Mediated Immunomodulation and Its Use with Checkpoint Inhibitors
por: Maardalen, Matilde, et al.
Publicado: (2023)

Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia
por: Lokerse, Wouter J.M., et al.
Publicado: (2016)

DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment
por: Lv, Qiang, et al.
Publicado: (2017)

Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel
por: Huang, Zhongming, et al.
Publicado: (2018)

Cholesterol Levels Affect the Performance of AuNPs-Decorated Thermo-Sensitive Liposomes as Nanocarriers for Controlled Doxorubicin Delivery
por: García, Mónica C., et al.
Publicado: (2021)

Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
por: Uldrick, Thomas, et al.
Publicado: (2010)

Thermosensitive liposomal drug delivery systems: state of the art review
por: Kneidl, Barbara, et al.
Publicado: (2014)

Multimodal targeted high relaxivity thermosensitive liposome for in vivo imaging
por: Kuijten, Maayke M. P., et al.
Publicado: (2015)

Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
por: Li, Yanan, et al.
Publicado: (2020)

Sertoli Cells Loaded with Doxorubicin in Lipid Micelles Reduced Tumor Burden and Dox-Induced Toxicity
por: Das, Mahasweta, et al.
Publicado: (2017)

Mollification of Doxorubicin (DOX)-Mediated Cardiotoxicity Using Conjugated Chitosan Nanoparticles with Supplementation of Propionic Acid
por: Siva, Durairaj, et al.
Publicado: (2022)

Lyso-glycosphingolipids: presence and consequences
por: van Eijk, Marco, et al.
Publicado: (2020)

Doxorubicin (DOX) Gadolinium–Gold-Complex: A New Way to Tune Hybrid Nanorods as Theranostic Agent
por: Khan, Memona, et al.
Publicado: (2021)

Hyperthermia and Thermosensitive Liposomes for Improved Delivery of Chemotherapeutic Drugs to Solid Tumors
por: Koning, Gerben A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_epomscao5ve8dd4ieqq0r83u4e